Acer, Taiwan hospital co-develop AI-based medical software
Aaron Lee, Taipei; Adam Hwang, DIGITIMES
Acer has disclosed it has worked with National Taiwan University Hospital to develop AI-based software to help doctors diagnose diabetic retinopathy, with the software becoming the first ophthalmological intellectual property licensed by Taiwan’s Food and Drug Administration.
Acer has worked with the hospital’s departments of ophthalmology and internal medicine to develop the software since 2017, using 50,000 retinal images from abroad to train an AI-based diagnostic model for interpreting retinopathy. The model has then been adjusted for improvement using 10,000 retinal images of diabetes patients treated by the hospital. Interpretation by the model can reach an accuracy rate of 95%, the same level as interpretation by ophthalmologist.
A major complication of diabetes, retinopathy is likely to cause blindness, according to a physician with the hospital. There are an estimated 2.2 million diabetics in